| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/978-3-319-05134-5_14 |
| P2093 | author name string | Josep Roma | |
| Soledad Gallego | |||
| José Sánchez de Toledo | |||
| Miguel F. Segura | |||
| Ana Almazán-Moga | |||
| P2860 | cites work | Identification of microRNAs as potential prognostic markers in ependymoma | Q21135016 |
| Use of preclinical models to improve treatment of retinoblastoma | Q21144714 | ||
| Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours | Q24298221 | ||
| Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility | Q24304444 | ||
| miR-17~92 cooperates with RB pathway mutations to promote retinoblastoma | Q24606181 | ||
| Molecular subgroups of medulloblastoma: the current consensus | Q24615271 | ||
| Mutation and cancer: statistical study of retinoblastoma | Q24618185 | ||
| The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1 | Q24629399 | ||
| The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors | Q24629817 | ||
| MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development | Q24648202 | ||
| The miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma | Q24657463 | ||
| Inhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticles | Q27301841 | ||
| MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma | Q27320938 | ||
| MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma | Q27350129 | ||
| EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma | Q27851507 | ||
| MicroRNA expression profiles classify human cancers | Q28032481 | ||
| Dickkopf-3 is regulated by the MYCN-induced miR-17-92 cluster in neuroblastoma | Q28117269 | ||
| Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy | Q28235397 | ||
| Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping | Q28236877 | ||
| Expression of miR-124 inhibits growth of medulloblastoma cells | Q28279686 | ||
| Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma | Q28284093 | ||
| Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib | Q29999611 | ||
| Molecular biology and therapeutics in musculoskeletal oncology | Q30426953 | ||
| Transcription mapping in a medulloblastoma breakpoint interval and Smith-Magenis syndrome candidate region: identification of 53 transcriptional units and new candidate genes | Q30640817 | ||
| Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data. | Q31157886 | ||
| The National Cancer Data Base report on patterns of childhood cancers in the United States | Q32172794 | ||
| Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features | Q33366431 | ||
| Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival | Q33516231 | ||
| MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence | Q33614641 | ||
| ATM is down-regulated by N-Myc-regulated microRNA-421. | Q33667539 | ||
| MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma | Q33803485 | ||
| Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification | Q33858202 | ||
| miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a | Q39076744 | ||
| miR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells | Q39105277 | ||
| MicroRNA-340 suppresses osteosarcoma tumor growth and metastasis by directly targeting ROCK1. | Q39122905 | ||
| Epirubicin-mediated expression of miR-302b is involved in osteosarcoma apoptosis and cell cycle regulation | Q39127244 | ||
| MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1. | Q39140942 | ||
| TGF-β1 suppression of microRNA-450b-5p expression: a novel mechanism for blocking myogenic differentiation of rhabdomyosarcoma | Q39153280 | ||
| MiR-365b-3p, down-regulated in retinoblastoma, regulates cell cycle progression and apoptosis of human retinoblastoma cells by targeting PAX6. | Q39154132 | ||
| MicroRNA-376c inhibits cell proliferation and invasion in osteosarcoma by targeting to transforming growth factor-alpha | Q39158217 | ||
| MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma | Q39158975 | ||
| MicroRNA-24 inhibits osteosarcoma cell proliferation both in vitro and in vivo by targeting LPAATβ. | Q39167853 | ||
| miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma | Q39178990 | ||
| MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A. | Q39196320 | ||
| MiR-383 is downregulated in medulloblastoma and targets peroxiredoxin 3 (PRDX3). | Q39228870 | ||
| Heat shock protein 90B1 plays an oncogenic role and is a target of microRNA-223 in human osteosarcoma | Q39233292 | ||
| Differentially expressed miRNAs in retinoblastoma | Q39252603 | ||
| miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma | Q39291006 | ||
| miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells | Q39291031 | ||
| MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome | Q39297570 | ||
| A TARBP2-dependent miRNA expression profile underlies cancer stem cell properties and provides candidate therapeutic reagents in Ewing sarcoma | Q39331421 | ||
| microRNA-9 targets matrix metalloproteinase 14 to inhibit invasion, metastasis, and angiogenesis of neuroblastoma cells | Q39352460 | ||
| Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma | Q39382947 | ||
| Downregulation of microRNAs miR-1, -206 and -29 stabilizes PAX3 and CCND2 expression in rhabdomyosarcoma | Q39397196 | ||
| miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3. | Q39441445 | ||
| miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy | Q39465507 | ||
| MicroRNA-21 suppression impedes medulloblastoma cell migration | Q39503647 | ||
| MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration | Q39526077 | ||
| MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma | Q39542401 | ||
| The miR-17-92 microRNA cluster regulates multiple components of the TGF-β pathway in neuroblastoma | Q39621978 | ||
| Oncogenic role of miR-483-3p at the IGF2/483 locus | Q39715206 | ||
| EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells | Q39716224 | ||
| MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors. | Q39769505 | ||
| Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples | Q39820788 | ||
| miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1. | Q39854644 | ||
| Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma | Q39964030 | ||
| The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas | Q40497319 | ||
| Notch1 and notch2 have opposite effects on embryonal brain tumor growth | Q40497328 | ||
| miR-125b develops chemoresistance in Ewing sarcoma/primitive neuroectodermal tumor | Q41051759 | ||
| Transactivation of Igf2 in a mouse model of Beckwith-Wiedemann syndrome. | Q41066237 | ||
| microRNA-195 suppresses osteosarcoma cell invasion and migration in vitro by targeting FASN. | Q41113931 | ||
| Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells | Q42009448 | ||
| MicroRNA profiling in human medulloblastoma. | Q43415716 | ||
| NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma | Q43896876 | ||
| Differential profiles of microRNAs in retinoblastoma cell lines of different proliferation and adherence patterns | Q44624930 | ||
| Gender affects survival for medulloblastoma only in older children and adults: a study from the Surveillance Epidemiology and End Results Registry | Q45240545 | ||
| MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells | Q45878313 | ||
| Embryonal cancers in Europe. | Q45906383 | ||
| Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells. | Q46011331 | ||
| Biallelic DICER1 mutations occur in Wilms tumours. | Q46977021 | ||
| Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors suppresses retinoblastoma formation | Q47302451 | ||
| miR-218 is downregulated and directly targets SH3GL1 in childhood medulloblastoma | Q47719797 | ||
| Stat3 inhibits WTX expression through up-regulation of microRNA-370 in Wilms tumor. | Q50485086 | ||
| Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? | Q50752435 | ||
| LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. | Q50781580 | ||
| MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma. | Q53201641 | ||
| Silencing of miR-124 induces neuroblastoma SK-N-SH cell differentiation, cell cycle arrest and apoptosis through promoting AHR. | Q53210793 | ||
| The Biology of Ewing sarcoma. | Q53575285 | ||
| Effect of curcumin on miRNA expression in human Y79 retinoblastoma cells. | Q54314330 | ||
| Pax6 regulates proliferation and apoptosis of human retinoblastoma cells. | Q54396510 | ||
| A proteomic approach of pediatric astrocytomas: MiRNAs and network insight. | Q55461473 | ||
| High incidence of DNA mutations and gene amplifications of theALKgene in advanced sporadic neuroblastoma tumours | Q61696748 | ||
| Incidence of second neoplasms in patients with bilateral retinoblastoma | Q68005406 | ||
| Infrequency of ras, p53, WT1, or RB gene alterations in Wilms tumors | Q72636441 | ||
| Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an intergroup rhabdomyosarcoma study | Q73553819 | ||
| Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin | Q83961794 | ||
| MicroRNA-21 is involved in osteosarcoma cell invasion and migration | Q84245716 | ||
| MicroRNA cloning and sequencing in osteosarcoma cell lines: differential role of miR-93 | Q85017897 | ||
| Micro-RNA-21 regulates the sensitivity to cisplatin in human neuroblastoma cells | Q85236809 | ||
| First microRNA mimic enters clinic | Q87067042 | ||
| Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group | Q33876841 | ||
| microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma | Q33893064 | ||
| Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells | Q33895297 | ||
| Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development | Q33997274 | ||
| Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors | Q34010180 | ||
| Wilms tumor genetics | Q34067724 | ||
| Accurate prediction of neuroblastoma outcome based on miRNA expression profiles | Q34115726 | ||
| Survey of MicroRNA expression in pediatric brain tumors | Q34154964 | ||
| MicroRNA involvement in the pathogenesis of neuroblastoma: potential for microRNA mediated therapeutics | Q34155009 | ||
| MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma | Q34163789 | ||
| Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway | Q34167348 | ||
| A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma | Q34178892 | ||
| Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma | Q34191041 | ||
| miR-335 and miR-363 regulation of neuroblastoma tumorigenesis and metastasis | Q34194661 | ||
| MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo | Q34211970 | ||
| EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance. | Q34283431 | ||
| Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma | Q34334974 | ||
| miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma. | Q34482630 | ||
| Diagnosis and current management of retinoblastoma | Q34570404 | ||
| MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma | Q34570975 | ||
| Growth-promoting role of the miR-106a~363 cluster in Ewing sarcoma | Q34702270 | ||
| miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma | Q34722558 | ||
| A clinical overview of WT1 gene mutations | Q34738955 | ||
| High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial | Q34756587 | ||
| Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis | Q34838128 | ||
| Loss of heterozygosity at 2q37 in sporadic Wilms' tumor: putative role for miR-562. | Q35005638 | ||
| Ewing's sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities | Q35057457 | ||
| MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression | Q35086698 | ||
| Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene | Q35095712 | ||
| miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. | Q35783986 | ||
| MiR-27b targets PPARγ to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cells | Q35791401 | ||
| MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway | Q35907425 | ||
| The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma. | Q35914487 | ||
| International variations in the incidence of childhood renal tumours. | Q35982229 | ||
| Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups. | Q36022696 | ||
| Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs | Q36335774 | ||
| Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. | Q36374350 | ||
| A statin-regulated microRNA represses human c-Myc expression and function. | Q36379501 | ||
| MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2. | Q36500392 | ||
| MicroRNA 218 acts as a tumor suppressor by targeting multiple cancer phenotype-associated genes in medulloblastoma | Q36543801 | ||
| Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets | Q36562726 | ||
| The E2F3-Oncomir-1 axis is activated in Wilms' tumor | Q36742470 | ||
| MicroRNA-34a inhibits human osteosarcoma proliferation by downregulating ether à go-go 1 expression | Q36746921 | ||
| MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1 | Q36766761 | ||
| Human chromosome 11 contains two different growth suppressor genes for embryonal rhabdomyosarcoma | Q36858083 | ||
| Medulloblastoma: from molecular pathology to therapy | Q37087083 | ||
| Management of Wilms tumor: current standard of care | Q37287143 | ||
| Osteosarcoma: Conventional treatment vs. gene therapy. | Q37355546 | ||
| Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression | Q37378211 | ||
| New therapeutic targets for the treatment of high-risk neuroblastoma | Q37412535 | ||
| Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor. | Q37437735 | ||
| Pediatric brain tumors: current treatment strategies and future therapeutic approaches | Q37533670 | ||
| Childhood medulloblastoma: current status of biology and treatment | Q37713662 | ||
| Pathology, genetics and cytogenetics of Wilms' tumour | Q37868410 | ||
| Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor | Q37874427 | ||
| Multidisciplinary management of childhood brain tumors: a review of outcomes, recent advances, and challenges | Q37909392 | ||
| Medulloblastomas: update on a heterogeneous disease | Q37926454 | ||
| Ewing sarcoma treatment | Q37937915 | ||
| Ewing sarcoma: biology-based therapeutic perspectives | Q37981253 | ||
| Pediatric neuro-oncology: current status and future directions. | Q38035070 | ||
| Prospects and challenges for the development of new therapies for Ewing sarcoma | Q38053823 | ||
| Models and discovery strategies for new therapies of retinoblastoma | Q38083299 | ||
| microRNAs as pharmacological targets in cancer. | Q38093917 | ||
| MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor | Q38321646 | ||
| A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs | Q38334606 | ||
| Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma | Q38338166 | ||
| MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration | Q38338974 | ||
| P304 | page(s) | 239-263 | |
| P577 | publication date | 2014-01-01 | |
| P1476 | title | miRNA-Targeted Therapies in the Most Prevalent Pediatric Solid Tumors |
Search more.